Osteoblasts are the cells responsible for the secretion of collagen and, ultimately the formation of new bone. These cells have also been shown to regulate osteoclast activity by the secretion of cytokines, which remain to be defined. In an attempt to identify these unknown cytokines, we have induced primary murine osteoblasts with two bone active agents, parathyroid hormone (PTH) and lipopolysaccharide (LPS) and analyzed the conditioned media (CM) for the presence of specific cytokines. Analysis of the CM was accomplished by functional biochemical, and serological techniques. The data indicate that both PTH and LPS are capable of inducing the osteoblasts to secrete a cytokine, which by all of the techniques used, is indistinguishable from granulocyte-macrophage colony-stimulating factor (GM-CSF). Secretion of GM-CSF is not constitutive and requires active induction. Production of the cytokine is dependent on the dose of PTH or LPS added. It has been demonstrated that the addition of GM-CSF to bone marrow cultures results in the formation of increased numbers of osteoclasts. Therefore, these data suggest that osteoblasts not only participate in bone remodeling by formation of new matrix but may regulate osteoclast activity indirectly by their ability to regulate hematopoiesis.
Introduction
Bone resorption is mediated by the action of mature activated osteoclasts. A number ofbiological agents are known to stimulate bone resorption in vitro. These agents include peptide hormones (parathyroid hormone), steroids (1,25-dihydroxyvitamin D) certain bacterial products (lipopolysaccharide), and cytokines of immune cell origin. The immune cell products can be derived from at least two cell types: T cells (tumor necrosis factor beta) and macrophages (tumor necrosis factor alpha and interleukin 1) (1, 2) .
Recent evidence indicates that certain of these agents (parathyroid hormone, PTH; IL-1; and tumor necrosis factor, TNF') require the presence of osteoblasts to activate osteoclasts to resorb bone (3, 4) . The physical presence ofthe osteoblast can be replaced by osteoblast-conditioned media, indicating that the osteoblast can interact with the osteoclast or osteoclast precursors, via release of a cytokine (s) (5) (6) (7) . The nature of the molecules secreted by the osteoblast that are responsible for osteoclast activation and subsequent bone resorption are poorly enumerated. These cytokines may have different target cells resulting in multiple pathways leading to osteoclast activation. Certain of these biological agents may activate existing osteoclasts directly, while others may induce the formation of new osteoclasts from resident progenitors. It has been demonstrated that granulocyte-macrophage colonystimulating factor (GM-CSF), a product ofT cells, endothelial cells, and keratinocytes (8) (9) (10) , and macrophage colony-stimulating factor (M-CSF), a product of L cells (1 1), do not directly induce bone resorption (12) , but rather induce the increased formation of osteoclasts from cultured bone marrow cells, suggesting that these cytokines can augment resorption by increasing the number ofosteoclasts available for activation (13) .
Previously,; we have found that conditioned media derived from both 17-d-old fetal rat long bones or isolated neonatal murine calvarial cells, stimulated with lipopolysaccharide (LPS) contains T cell growth factor activity (TCGF) as measured by proliferation of a TCGF responsive T cell line. This activity is however, restricted in its pattern of T cell activation (14) . This observation is unusual in two regards. Although activated T cells are known to be the primary source of TCGF activity (IL-2, IL-4) (15) (16) (17) , mature T cells are absent in 1 7-d-old fetal rat long bones (18) . Second, LPS is not known to directly activate T cells to proliferate or secrete TCGF (19) .
These data suggests that it is the bone cells and not resident immune cells in the bones that are responsible for the production of this unusual TCGF activity. This is supported by data showing that CM from in vitro cultures of bone marrow depleted femurs from endotoxin injected adult mice produce GM-CSF activity (20) . It is therefore important to identify the cellular source of this cytokine, determine the signals that regulate its release, and compare this activity to other well characterized TCGFs. We show that isolated murine calvarial cells that display an osteoblastic phenotype can be induced with either PTH or LPS to produce a cytokine that has functional, chemical, and serological properties indistinguishable from GM-CSF. GM-CSF may represent one of the coupling factors that link bone resorption with bone formation. The role of osteoblast-derived cytokines as paracrine modulators of osteoclast activity and hematopoiesis is discussed. These data support the idea that a strong association exists between the cells of the immune system and the cells of the skeletal system and that the interactions between cells of these two systems are mediated, at least in part, by cytokines.
Methods
Cells. Monolayer cultures of murine calvarial cells were prepared as previously described (21) . Our technique is a modification of the basic method described by Wong and Cohn (22) . Briefly, calvaria from 3 to 5-d-old C57BL/6J mice were pretreated with EDTA in PBS for 30 min. The calvaria were then subjected to sequential enzymatic digestion using CLS II bacterial collagenase (Cooper Biomedical, Malvern, PA) at 180 U/ml in PBS over a 50-min period. Cells released after the first 0-min digestion were designated fractions 1 and 2; cells released after the second 10-min digestion period were designated fractions 3 and 4 and cells released in the third 0-min digestion period were designated fractions 5 (25) , in addition to the osteoblasts that predominate. The low density population is characterized by its inability to develop osteoclasts in response to resorptive agents and macrophages are undetectable as measured by staining. After growth to confluence the low density population is highly enriched for osteoblasts as evidenced by in vitro bone formation and a rise in cAMP in response to PTH (26, 27 Horizontal isoelectricfocusing. Cell-free supernantants were extensively dialyzed against deionized water. Ampholytes, pH 3-10 (BioRad Laboratories) were added to 1 ml of the retentate at a final concentration of 2% (vol/vol). This material was added to a 20 X 20-cm electrofocusing tray that contained 50 ml electrofocusing gel (Bio-Rad Laboratories) with 2% ampholytes pH 3-10. The anode was 20 mM aspartic acid and 20 mM glutamic acid. The cathode solution was 2 M ethanolamine, 20 mM lysine free base, and 20 mM arginine. Electrofocusing was conducted in a Bio-Phoresis horizontal electrophoresis cell (Bio-Rad Laboratories) at 4-10°C for 4 h at a constant power of 14 W. At the completion ofthe run, the fractions were removed, 1.5 ml of H20 was added, and the pH was measured with a combination pH electrode. Each fraction was subsequently dialyzed extensively against 10 mM Na2HPO4/NaH2PO4, pH 7.4, filtered through a 0.45-am fluoropolymer membrane (Gelman Sciences), and assayed for TCGF activity.
Results
Bone cells were seeded at either high or low density and allowed to grow to confluence. A comparison between low and high density cells was made because the populations of cells which arise from these initial seeding densities are distinct (see Methods). The bone cell monolayers were washed and recultured for either 48 or 96 h in the presence ofeither lipopolysaccharide (LPS, 10 ug/ml) or parathyroid hormone (PTH, 10 nM). The CM was collected and tested for its ability to induce To directly compare the ability of PTH with LPS to induce HT-2 stimulating activity, varying doses of the reagents were added to confluent monolayers of high density cells and cultured for 96 h. The CM was collected and tested for its ability to induce HT-2 cell proliferation. The data in Fig. 2 show that PTH induces the secretion of HT-2 stimulating activity in a dose-dependent fashion from 0.12 to 3.3 nM. LPS was also capable of inducing HT-2 stimulating activity in dose-dependent fashion from 0.0001 to 1 ,ug/ml. These data suggests that at low concentrations PTH and LPS are approximately equal in their ability to induce HT-2 stimulating activity from the bone cells. However, LPS is stimulatory over a broader concentration range.
We next investigated whether a similar pattern of responsiveness was observed using calvarial cells initially seeded at low density and grown to confluence. (Fig. 4) . This peak corresponds to a molecular weight range of between % added CM 20 to 30,000 with a peak at 27,000. These data make it unlow density seeded likely that the HT-2 stimulating activity is CSF-1, which has a r PTH. CM derived molecular weight of 70,000. In addition, CM rich in CSF-l Is, which are highly fails to stimulate HT-2 cell proliferation.3 Because no other ,re induce with (A) 10 peaks of activity can be detected it is also unlikely that a small -* -) or 96 (-* -) h molecular weight molecule could account for the observed proliferation. Increasproliferation. However, IL-2, IL-4, and GM-CSF can all be ith the TCGF dependent found in this molecular weight range. h in a final volume of
The isoelectric point of the HT-2 stimulating activity was measured as described in Methods. CM from LPS-activated low density seeded osteoblasts was used. After horizontal isoactivity in electric focusing, each fraction was assayed for biological activstimulating activity in ity at 25 and 12.5% (by volume). The results at the two cons seen as a dose-depencentrations were similar. Data in Fig. 5 show the HT-2 stimutse of HT-2 cells (Fig. 3 lating activity to be maximal in fraction 21, which corresponds A). These data are similar to those seen with the high density cells (Fig. 1 A) however, 3-to 10-fold more activity is being secreted by the low density population (depending on the particular experiment). In contrast to the high density cells, which are poor responders to PTH (Fig. 1 B) , low density cells when cultured with 10 nM PTH produce CM, which is highly stimulatory for HT-2 cells (Fig. 3 B) 44 and 45% (not shown). The functional activity of each fraction was tested for biological activity by induction of HT-2 cell proliferation. Data in Fig. 6 
TCGF-dependent T cell lines including: (a) CTLL-2 cells, (b)
CT-6 cells, and (c) Con A activated T cell blasts. The data in Fig. 7 show that, at all concentrations tested, the osteoblast derived CM, which had previously been shown to stimulate the proliferation of HT-2 cells, failed to stimulate any of the other T cell preparations. All of the cells respond to rIL-2 indicating that the cells are capable of responding to the appropriate growth signal. CTLL cells are known to respond to both IL-2 and IL-4 while CT-6 and Con A activated T cell blasts respond to IL-2 (34).3 These data suggest that the HT-2 stimulating activity present in the osteoblast CM is neither IL-2 nor IL-4.
Antibody blocking studies were then used as a tool to further characterize the HT-2 stimulating activity. To demonstrate specificity of the various antibodies, they were tested independently for their ability to block functional activity of their corresponding cytokines. Antibodies with specificities for the murine IL-2 receptor (PC61 + 7D4), IL-4 (11 B 1), and GM-CSF (anti-GM-CSF) were added to cultures of HT-2 cells stimulated with rIL-2, affinity purified IL-4 or rGM-CSF, respectively. Data in Fig. 8 show that each individual antibody is able to block that cytokine for which it has specificity and fail to exhibit any nonspecific blocking activity. Similar specificity data has been obtained using S4B6, an antibody to murine IL-2 (data not shown) (29) . These data establish the specificity of the antibodies used. A similar experiment was then con- This work demonstrates that a population of murine calvarial cells highly enriched in osteoblasts can be activated with either PTH or LPS to secrete an HT-2 cell (T cell) growth factor. The data indicate that the growth factor secreted by the osteoblasts is indistinguishable from granulocyte-macrophage colony stimulating factor. This conclusion is supported by functional, biochemical, and serologic data. The HT-2 stimulating activity secreted by either PTH or LPS activated osteoblasts have very similar functional and biochemical properties. At equimolar concentrations, PTH and LPS induce the cells to secrete approximately equal amounts of GM-CSF. However, increasing concentrations of LPS induces the secretion of more cytokine. This is not the case for PTH, which reaches maximal stimulation at a level of released cytokine well below the maximum Figure 8 . Antibody specificity. Anti-IL-4 (1 I B I at 1:1,000 dilution), anti-IL-2R (alpha 7D4 + PC -61 at 1:10 dilution) and anti-GM-CSF (at 1:1000 dilution) were tested for their ability to specifically inhibit their corresponding cytokine. To test for neutralizing activity, HT-2 cells (2 X IO' cells/well) were cocultured with rIL-2 (2.5 U/ml), affinity purified IL-4 (100 U/ml), or rGM-CSF (10-6 dilution; -1-5 U/ml) in the presence or absence of the neutralizing antibodies for 48 h. Controls: HT-2 cells plus media 980±60 SEM. ducted using the CM from both LPS (Fig. 9 A) and PTH (Fig. 9  B) induced low density seeded osteoblast cultures. Varying concentrations of CM derived from the two groups of induced osteoblasts was cocultured with HT-2 cells to which the neutralizing antibodies were added. The ability to inhibit the proliferative response of the HT-2 cells by the antibodies was measured. These data are identical for both the LPS and the PTH-induced osteoblast CM. Conditioned media in the absence of any blocking antibody induces a dose-dependent increase in the proliferative response of the HT-2 cells similar to that already described. The addition of antibodies capable of neutralizing either IL-2 or IL-4 fail to inhibit the proliferative response of the HT-2 cells. However, addition of antibody neutralizing for GM-CSF blocks to background the proliferative response of the HT-2 cells at all concentrations tested. This observation agrees with the functional and biochemical does not induce HT-2 cell proliferation.3 Equally unlikely, is the factor reported by McSheehe, which is derived from osteosarcoma cells (UMR 106) that are induced with PTH (5). This material induces bone resorption and has a molecular weight of < 1,000. The HT-2 stimulating activity of primary osteoblast derived CM can be blocked completely with a polyclonal goat antibody to murine GM-CSF. This antibody fails to show cross-reactivity with M-CSF, G-CSF, IL-3, IL-4, IL-2, and IL-1.2 In addition, we have shown that CM from both PTH and LPS stimulated osteoblasts is able to promote the formation ofbone marrow colonies in soft agar.3 Three distinct morphological types of colonies could be discerned. First, tight clusters of round small cells which are granulocytes were present, although these were few in number. Second, loosely associated colonies of large cells which are macrophages were also found. Third and most numerous, were the large mixed type that contained both the small round cells and the larger macrophages. This pattern of colonies is characteristic of the types GM-CSF induces (40). These data in conjunction with the other functional and biochemical data strongly support the contention that the HT-2 stimulating activity is GM-CSF. We cannot however, completely eliminate the possibility that a unique cytokine with functional, biochemical, and antigenic characteristics similar to GM-CSF is not responsible for the observed activity. This possibility seems unlikely. Our data is consistent with and extends that of Felix et al. who has shown that CM from cultured whole murine calvaria and unseparated calvarial cells contains GM-CSF (41).
We have recently described a cytokine derived from murine keratinocytes with essentially identical functional and biochemical characteristics as the osteoblast-derived material (10) . This factor is referred to as keratinocyte derived T cell growth factor or KTGF. We have purified this cytokine 47,000-fold and shown that it is GM-CSF (36) .
The possibility exists that the GM-CSF activity we have observed is derived from cells other than the osteoblasts that are present in the cell preparation. Macrophages appear to be the most likely candidates as an alternative source ofGM-CSF. We are not excluding the possibility that osteoclasts may also be a source of GM-CSF, especially if osteoclasts are members of the macrophage lineage (42, 43) . Macrophages can release GM-CSF after activation with LPS (44) . However, no data is available that addresses whether osteoclasts are able to secrete cytokines. The possibility that macrophages are the source of GM-CSF seems unlikely for the following reasons. First, the number of contaminating macrophages comprises < 0.1% of the total cells in the low density population and < 5% of the total cells in the high density population as determined by numbers of antibody dependent erythrophagocytic cells. The high density population produces less GM-CSF activity after LPS stimulation than the low density population even though it contains more macrophages. Second, osteoblasts but not macrophages possess receptors for PTH (45) . In fact, monocytes are known to degrade the hormone (46) . This would suggest that the ability of PTH to induce GM-CSF production in our cultures is the result of its action on cells other than macrophages. Third, we have been able to demonstrate that the rat derived, cloned osteosarcoma cell line ROS 17/2.8 and the cloned nontransformed murine osteoblastic cell line MC3T3-El, which are maintained in vitro, and therefore do not contain any contaminating cell types, can also secrete GM-CSF when stimulated in a fashion similar to that used for the calvarial cells (46a, 47).
A second possibility is that T cells, one of the major sources of GM-CSF are responsible for the observed activity. Although LPS is not known to activate T cells, these cells are known to possess receptors for, and can be activated by PTH (46, 48, 49 ). This possibility is also highly unlikely since few mature functional T cells are present in the periphery of neonatal mice (35) . In addition, the CM used throughout these experiments is prepared from adherent bone cell monolayers. Nonadherent cells are removed by extensive washing. Quiescent T cells are nonadherent.
It is interesting to note that the high density seeded cells routinely respond less vigorously to LPS and almost not at all to PTH, as measured by GM-CSF activity, in comparison to the low density seeded cells. This difference could be explained if the high density seeded population contained less cells per tissue culture well. This however, is not the case. In fact, the high density population has more cells per well than the low density population. The over riding population present in both cultures is actively growing preosteoblasts (26, 27) . The nonosteoblastic cells account for only 5-10% of the total cells present in the high density seeded population. Therefore, it seems unlikely that this small percentage of cells could dilute the osteoblasts sufficiently to result in the reduced level of activity present in the high density seeded population. An alternative explanation for this diminished response is that the nonosteoblastic cells present in the high density population that are not present in the low density population may be actively inhibiting the osteoblasts from secreting the GM-CSF by the secretion of an inhibitor. TGF# is a possible candidate for this inhibitory molecule. Bone cell CM contains TGFB, the activity of which can be increased following PTH stimulation (50) and it is an inhibitor of T cell growth (5 1). The possibility that TGFB is inhibiting at the level ofthe assay is unlikely since HT-2 cell proliferation is insensitive to the effects of TGF#.3
Another possibility is that the large amount of matrix present in the high density population, which can be seen with scanning electronmicroscopy,5 may be binding the growth factor in a fashion analogous to that seen with bone marrow matrix (52) .
It has become apparent that bone cells and particularly osteoblasts not only participate in the regulation of skeletal homeostasis but may also function as a regulating component of hematopoiesis. In addition to the secretion of GM-CSF osteoblasts secrete what is apparently macrophage colony stimulating factor (38) . This CSF is specific for macrophages, has similar functional activity to GM-CSF but is the product of a distinct gene (39) . Thus osteoblasts secrete at least two of the four major CSFs making osteoblasts potentially significant regulatory cells in hematopoietic function. This is supported by the idea that osteoblasts are terminally differentiated members of the stromal cell family (53). One of the major functions of stromal cells is to secrete various cytokines that maintain the microenvironment required for hematopoiesis (54) . The ability of osteoblasts to secrete GM-CSF and M-CSF is consistant with their stromal cell lineage. It was thought until recently that the agents which induce osteoclastic bone resorption functioned by direct activation of the osteoclast. Included in this list of inducing agents was PTH, IL-1, TNF, and 1,25(OH)2 vitamin D3. Recent data suggest that this is not the case for many of these agents. Osteoclasts stimulated with PTH, IL-1, and TNF fail to resorb 5. Jilka, R., unpublished observation. bone unless they are cocultured with either osteoblasts or CM from cultures of osteoblasts (5) (6) (7) . This is substantiated by the observation that osteoclasts do not have receptors for PTH while osteoblasts do (45) . These data suggest that a soluble factor(s) is secreted by intermediate cells, which is required by osteoclasts to resorb bone. One obvious candidate for this intermediate cell is the osteoblast. MacDonald has shown that GM-CSF, and to a lesser extent M-CSF, when cocultured with bone marrow cells, results in the formation of cells with many of the characteristics of osteoclasts ( 13) . Therefore, GM-CSF, which has previously been shown to be a product ofT cells (8) , keratinocytes (10) , endothelial cells (9) , and now of osteoblasts, may be participating in bone resorption by regulating osteoclasts in two ways. First, osteoblasts once activated by specific signals (i.e., PTH, LPS, IL-1, and TNF) release GM-CSF. This cytokine works in a paracrine fashion, by leaving the bone and entering the adjacent marrow where it stimulates replication of multipotential progenitor cells (CFU-GM). Once acted upon these cells can differentiate to osteoclast precursors (55) . These cells then become available for additional differentiation signals (i.e., 1,25(OH)2D3) to yield mature osteoclasts. This idea is consistent with the observations of Lorenzo et al. (12) . Second, GM-CSF is known to exert functional changes in mature cells (56) . These functional changes include activation of neutrophils and increased phagocytic activity (57). Osteoblast-derived GM-CSF may act alone or in concert with other cytokines to activate mature osteoclasts in a similar fashion to resorb bone.
The idea that osteoclast precusors are derived exclusively from granulocyte-macrophage-colony forming cells remains an open question in light ofthe data of Schneider and Relfson (58). They show that enriched populations of granulocyte (G-CFC) and granulocyte-macrophage-colony forming cells (GM-CFC) derived from the bone marrow of normal littermates of incisor absent (ia) rats were effective in curing the osteopetrotic condition and giving rise to osteoclasts when adoptively transfered to incisor absent rats. On the other hand, macrophage-colony forming cells were totally ineffective in both curing the skeletal defect and giving rise to osteoclasts. One interpretation of this data is that the osteoclast precursor is in the granulocyte lineage. Alternatively, the precusors may have been co-purified with the G-CFCs.
Coupling factors are thought to be released by mononuclear phagocytes following the resorption phase and act on osteoblast precursors or osteoblasts to induce the formation of new bone (59) . Although GM-CSF and other similar osteoblast derived cytokines are not coupling factors in the strict sense of the term, nonetheless these growth factors can be considered as promoting factors for bone resorption and function to link osteoblasts with osteoclasts.
